This brand name is authorized in Spain, Finland, Lithuania
The drug SABRILEX contains one active pharmaceutical ingredient (API):
|
1
Vigabatrin
UNII GR120KRT6K - VIGABATRIN
|
|
Vigabatrin is a selective irreversible inhibitor of GABA transaminase, the enzyme responsible for the breakdown of GABA (gamma aminobutyric acid). Vigabatrin increases the concentration of GABA, the major inhibitory neurotransmitter in the brain. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N03AG04 | Vigabatrin | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 59361, 59809 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 539031, 539049 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1080062, 1080063 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
